Pulmonary hypertensive crisis in children with pulmonary arterial hypertension undergoing cardiac catheterization

Qiangqiang Li1, Chen Zhang1, Rong Wang2

  • 1Department of Pediatric Cardiology, Beijing Anzhen Hospital Capital Medical University Beijing China.

Insights

Pulmonary hypertensive crisis (PHC) during right heart catheterization (RHC) is a significant risk for pediatric pulmonary arterial hypertension (PAH) patients. Sedation and severe right ventricle dilation independently predict PHC in these children.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Pulmonary Hypertension Research

Background:

  • Pediatric pulmonary arterial hypertension (PAH) patients face risks of pulmonary hypertensive crisis (PHC) or death during right heart catheterization (RHC).
  • Identifying risk factors is crucial for improving procedural safety in this vulnerable population.

Purpose of the Study:

  • To identify the risks and clinical characteristics associated with PHC in pediatric PAH patients undergoing diagnostic RHC.
  • To analyze predictors of PHC in this cohort.

Main Methods:

  • Retrospective analysis of 163 RHC procedures in 147 pediatric PAH patients (January 2007-December 2020).
  • Data collected included patient demographics, NYHA class, anesthetic methods, and echocardiographic indices.
  • Multivariate logistic regression was used to identify independent predictors of PHC.

Main Results:

  • PHC occurred in 11.7% of procedures; 3.1% required cardiac compression, and 0.6% died.
  • Patients experiencing PHC were more likely to be in NYHA class III-IV, require sedation, and have higher peak tricuspid regurgitation velocity and RV/LV ratio.
  • Independent predictors for PHC were the need for sedation and a higher RV/LV ratio.

Conclusions:

  • RHC carries significant risks for children with PAH, especially those with severe right ventricle dilation requiring sedation.
  • Comprehensive pre-procedural evaluation, close monitoring, and tailored treatment are essential to mitigate PHC risks and reduce mortality.

Related Concept Videos

Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
198
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
208
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
70
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
302
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
267
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
223